Ioannis Gkouzionis

Aisthesis Medical introduces an advanced clinical decision-support software, VIOSync, designed to revolutionise the management of sepsis in hospital settings. At its core, this tool harnesses explainable artificial intelligence (XAI) to analyse multimodal patient data, facilitating early and accurate predictions of sepsis onset. This innovative approach surpasses traditional screening methods, enabling timely medical interventions that are crucial for improving patient survival rates and reducing the overall healthcare burden associated with sepsis treatment. At its core, VIOSync utilises groundbreaking AI technology to provide early detection and management of life-threatening conditions such as sepsis. By harnessing the power of real-time data analysis, continuous patient monitoring, and personalised health assessments, VIOSync enhances the clinical outcomes and improve the efficiency of healthcare delivery in at least 30% of the cases. Developed with the clinician in-mind, VIOSync is engineered for ease of use and seamless integration into existing hospitals’ electronic health records (EHR), ensuring minimal disruption to clinical workflows. By providing healthcare professionals with a powerful, intuitive tool, VIOSync aims to enhance the precision of sepsis management, allowing for more targeted and effective patient care. In addressing one of the most pressing healthcare challenges today, VIOSync embodies a significant step forward in the application of AI technologies for enhancing patient care outcomes. Its deployment is expected to lead to a paradigm shift in how sepsis is managed across healthcare settings, marking a new milestone in the use of technology to tackle critical medical conditions.